Session Information
2007 Midyear Clinical Meeting
Advances in Women's Health Pharmacotherapy
Track: Educational Session
Program Code: 225-L01
Date: Monday, December 3, 2007
Time: 2:00 p.m. - 3:30 p.m.
Location:
Veronese 2401/2402/2501/2502MEETING PLANNING ASSOCIATE:
Dr. Karim Calis, PharmD, MPH, Director, Drug Information Service and Clinical Specialist, Mark O. Hatfield Clinical Research Center, National Institutes of Health
MODERATOR:
Karim Calis
PRESENTERS:
Dr. Karim Calis, PharmD, MPH, Director, Drug Information Service and Clinical Specialist, Mark O. Hatfield Clinical Research Center, National Institutes of Health
Dr. Frank Pucino, PharmD, BCPS, Ambulatory Care Clinical Pharmacy Team Leader, National Institutes of Health
LEARNING OBJECTIVES
- Describe the pathophysiologic mechanism underlying premature ovarian insufficiency.
- Discuss the clinical features of primary and secondary amenorrhea.
- Select appropriate treatment regimens for primary amenorrhea and premature ovarian failure.
- Describe the epidemiology and prognosis of cardiovascular disease in post menopausal women.
- Compare the evidence in the use of aspirin for primary prevention of heart disease in post menopausal women. List postential complications associated with aspirin therapy in older women.
Audio Synchronized to PowerPoint with MP3 Download
(Code: 225-L01)
This session is a part of: